US Budget Stopgap, FDA User Fee Reauthorization On Tap Minus Supplement MPL Program

With current user fee package as well all federal spending programs for FY2022 expiring on 30 September, House and Senate committee leaders reach agreement on FDA user fee reauthorization included in a continuing resolution to extend federal spending at current levels through 16 December.